Scientists have found a rotavirus vaccine against the diarrheal disease that kills about 600 children a day worked well in a large a trial in Africa. The doctors are reported that's thing appears to be a practical way to protect millions of children.

According to The New York Times, the new vaccine is rotavirus, the most common cause of death from diarrhea in children under the age group of 5. The vaccine is manufactured by an Indian company and was tested in Niger by Doctors without Borders.

The medical researchers have stated that the vaccine is expected to be as cheap as or cheaper than current alternatives. The new rotavirus vaccine can last for a month without refrigeration, which makes far easier to use the vaccine without electricity in the remote village.

The New England Journal of Medicine has reported that the new vaccine of rotavirus must be approved by the World Health Organisation. The doctors stated that the approved process is still underway, experts hailed the new vaccine as a leap forward.

As per the report from WHO, almost 215,000 children under the age of 5 die every year by rotavirus. The figure is almost half in just four countries: India, Pakistan, Nigeria and the Democratic Republic of Congo.

A leading research was sponsored by the Bill and Melinda Gates Foundation that found that rotavirus was the leading of fatal diarrhea in children under the age group of 2. The only major one not caused by bacteria which are treatable with antibiotic and antiphrastic drugs.

Around 300 medical personnel were involved in the trial in Niger. Trained health workers have spent 24 hours a day in each of the 132 villages that the 3,500 in the study live in.

However, the study report was published in the New England Journal of Medicine. The journal report pointed out that the vaccine was made by the Serum Institute of India was 67 percent effective in preventing severe episodes of rotavirus-related diarrhea.

Related